FCM
AGN

Farallon Capital Management’s Allergan plc AGN Stock Holding History

Farallon Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-216,000
Closed -$55.6M – 103
2014
Q4 		$55.6M Buy
+216,000
New +$54M 0.76% 39

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Farallon Capital Management's AGN Position: Q2 2020 in Review

Farallon Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,300,000 shares — an estimated $1.65B sold.

Farallon Capital Management first reported a position in AGN in Q4 2013 and held it in 16 quarters. The position peaked at $1.65B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Farallon Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Farallon Capital Management sold 9,300,000 Allergan plc shares in Q2 2020, an estimated $1.65B.
  • Farallon Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 16 quarters.
  • Farallon Capital Management's Allergan plc position peaked at $1.65B in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Farallon Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.